213 related articles for article (PubMed ID: 29778883)
1. Hyaluronic-acid-modified lipid-polymer hybrid nanoparticles as an efficient ocular delivery platform for moxifloxacin hydrochloride.
Liu D; Lian Y; Fang Q; Liu L; Zhang J; Li J
Int J Biol Macromol; 2018 Sep; 116():1026-1036. PubMed ID: 29778883
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional properties of organic-inorganic hybrid nanocomposites based on chitosan derivatives and layered double hydroxides for ocular drug delivery.
Xu T; Zhang J; Chi H; Cao F
Acta Biomater; 2016 May; 36():152-63. PubMed ID: 26940970
[TBL] [Abstract][Full Text] [Related]
3. Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: Design, optimization, and in vitro/ex vivo evaluation.
Alvarez-Trabado J; López-García A; Martín-Pastor M; Diebold Y; Sanchez A
Int J Pharm; 2018 Jul; 546(1-2):20-30. PubMed ID: 29753904
[TBL] [Abstract][Full Text] [Related]
4. Ocular tolerance to a topical formulation of hyaluronic acid and chitosan-based nanoparticles.
Contreras-Ruiz L; de la Fuente M; García-Vázquez C; Sáez V; Seijo B; Alonso MJ; Calonge M; Diebold Y
Cornea; 2010 May; 29(5):550-8. PubMed ID: 20335805
[TBL] [Abstract][Full Text] [Related]
5. The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():559-68. PubMed ID: 27164496
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: Mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability.
Zeng W; Li Q; Wan T; Liu C; Pan W; Wu Z; Zhang G; Pan J; Qin M; Lin Y; Wu C; Xu Y
Colloids Surf B Biointerfaces; 2016 May; 141():28-35. PubMed ID: 26820107
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronan-modified core-shell liponanoparticles targeting CD44-positive retinal pigment epithelium cells via intravitreal injection.
Gan L; Wang J; Zhao Y; Chen D; Zhu C; Liu J; Gan Y
Biomaterials; 2013 Aug; 34(24):5978-87. PubMed ID: 23680367
[TBL] [Abstract][Full Text] [Related]
8. Construction and Evaluation of Hyaluronic Acid-Coated Flurbiprofen-Layered Double Hydroxide Ocular Drug Delivery System.
Gu D; Pan H; Xu S; Chen W; Zhu R; Jiang W; Pan W
AAPS PharmSciTech; 2022 Oct; 23(8):287. PubMed ID: 36266593
[TBL] [Abstract][Full Text] [Related]
9. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
Li J; Tan G; Cheng B; Liu D; Pan W
Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
[TBL] [Abstract][Full Text] [Related]
10. [Vitro study on gene transfection efficiency of hyaluronic acid modified core-shell liponanoparticles in human retinal pigment epithelium cells].
Zhao YN; Gan L; Wang J; Chen X; Jia Z; Gan Y; Liu JP
Yao Xue Xue Bao; 2014 May; 49(5):711-7. PubMed ID: 25151745
[TBL] [Abstract][Full Text] [Related]
11. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
[TBL] [Abstract][Full Text] [Related]
12. Targeted delivery of hyaluronic acid to the ocular surface by a polymer-peptide conjugate system for dry eye disease.
Lee D; Lu Q; Sommerfeld SD; Chan A; Menon NG; Schmidt TA; Elisseeff JH; Singh A
Acta Biomater; 2017 Jun; 55():163-171. PubMed ID: 28363785
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional organic-inorganic hybrid nanoparticles and nanosheets based on chitosan derivative and layered double hydroxide: cellular uptake mechanism and application for topical ocular drug delivery.
Chi H; Gu Y; Xu T; Cao F
Int J Nanomedicine; 2017; 12():1607-1620. PubMed ID: 28280329
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
J Drug Target; 2010 May; 18(4):292-302. PubMed ID: 19943753
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic Acid-Modified Cationic Lipid-PLGA Hybrid Nanoparticles as a Nanovaccine Induce Robust Humoral and Cellular Immune Responses.
Liu L; Cao F; Liu X; Wang H; Zhang C; Sun H; Wang C; Leng X; Song C; Kong D; Ma G
ACS Appl Mater Interfaces; 2016 May; 8(19):11969-79. PubMed ID: 27088457
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of a composite system combining solid lipid nanoparticles and thermosensitive hydrogel for challenging ophthalmic drug delivery.
Hao J; Wang X; Bi Y; Teng Y; Wang J; Li F; Li Q; Zhang J; Guo F; Liu J
Colloids Surf B Biointerfaces; 2014 Feb; 114():111-20. PubMed ID: 24176890
[TBL] [Abstract][Full Text] [Related]
17. Intracellular trafficking of hyaluronic acid-chitosan oligomer-based nanoparticles in cultured human ocular surface cells.
Contreras-Ruiz L; de la Fuente M; Párraga JE; López-García A; Fernández I; Seijo B; Sánchez A; Calonge M; Diebold Y
Mol Vis; 2011 Jan; 17():279-90. PubMed ID: 21283563
[TBL] [Abstract][Full Text] [Related]
18. Hyalugel-integrated liposomes as a novel ocular nanosized delivery system of fluconazole with promising prolonged effect.
Moustafa MA; Elnaggar YSR; El-Refaie WM; Abdallah OY
Int J Pharm; 2017 Dec; 534(1-2):14-24. PubMed ID: 28987453
[TBL] [Abstract][Full Text] [Related]
19. Novel surface-modified nanostructured lipid carriers with partially deacetylated water-soluble chitosan for efficient ocular delivery.
Tian B; Luo Q; Song S; Liu D; Pan H; Zhang W; He L; Ma S; Yang X; Pan W
J Pharm Sci; 2012 Mar; 101(3):1040-9. PubMed ID: 22102480
[TBL] [Abstract][Full Text] [Related]
20. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
